Pulmonary Arterial Hypertension: What do I look for in referrals and how do I manage?

A lot of emphasis has been given to early diagnosis, early escalation of therapy in the latest 2022 ERS/ESC PAH guideline. In this talk, we will be discussing on how we can help in accelerating the referral process what you can/should do to perform the initial investigations. Addressing the many limitations with regards to initiating PAH-specific medications due to its cost. It is well known that delayed diagnosis will lead to poorer outcome, therefore, in this session we will be looking into improving this unmet need.